I don’t consider the Lassonde curve irrelevant just because DRE are explorers.
I agree that DRE have stated their intentions as explorers, and they have a multitude of targets that are scheduled for drilling - And one way to break the Lassonde curve is to keep making significant discoveries (hope they do).
But given the significance of Yin and the additional surrounding targets I can’t see DRE monetising any of that anytime soon – they have a significant part of what may well end up becoming a world class REE mineralised district (however its early days still). So, generally speaking the more DRE keep turning up the heat with the REE’s at Yin and surrounding targets and work towards producing a maiden MRE the more this is going to underpin the value. So the risk profile is going to evolve, and shareholder dynamic is going to change as that occurs.
Obviously, its a gross simplification and there are a whole stack of variables that may result in deviations or departures – continuing results, REE demand, market conditions, divestment of other assets, etc.
But as a general model with which to view the potential longer-term trends, its a useful framework to consider – particularly when an emerging discovery (asset) is involved.
Personally I feel there is a long way to go on the ‘speculation’ high-growth part of the curve with DRE – just not sure I would discount the model over the longer term because DRE are explorers and not miners.
all just IMO.
- Forums
- ASX - By Stock
- DRE
- DRE Small Caps Interview 30/08/2022
DRE Small Caps Interview 30/08/2022, page-127
-
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DRE (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.3¢ |
Change
0.001(4.55%) |
Mkt cap ! $80.80M |
Open | High | Low | Value | Volume |
2.2¢ | 2.3¢ | 2.2¢ | $110.4K | 5.021M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1488999 | 2.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.3¢ | 612995 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1488999 | 0.022 |
15 | 2097618 | 0.021 |
14 | 11140993 | 0.020 |
8 | 6143629 | 0.019 |
6 | 5363800 | 0.018 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 612995 | 3 |
0.024 | 1266722 | 9 |
0.025 | 465246 | 4 |
0.026 | 2000238 | 5 |
0.027 | 782467 | 4 |
Last trade - 12.30pm 15/07/2024 (20 minute delay) ? |
Featured News
DRE (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online